Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling

BACKGROUND: Post treatment minimal residual disease (MRD) determination contributes to impending relapse prediction, chemotherapy response and clinical outcomes assessment, guiding clinicians to develop reasonable and effective individual chemotherapy options after induction/consolidation. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Ju, He, Aili, Zhang, Wanggang, Huang, Chen, Yang, Juan, Yang, Yun, Wang, Jianli, Zhang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751134/
https://www.ncbi.nlm.nih.gov/pubmed/23915341
http://dx.doi.org/10.1186/1477-5956-11-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751134/
https://www.ncbi.nlm.nih.gov/pubmed/23915341
http://dx.doi.org/10.1186/1477-5956-11-39

Ejemplares similares